ArticleExperimental hematology & oncology2026

Targeting adaptive EGFR feedback enhances the therapeutic efficacy of RMC-6236 in cholangiocarcinoma.

Shiori Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.